Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals

INTRODUCTION: Plasma amyloid β (Aβ) peptides have been previously studied as candidate biomarkers to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. METHODS: Free and total Aβ42/40 plasma ratios (FP42/40 and TP42/40, respectively) were determined...

Descripción completa

Detalles Bibliográficos
Autores principales: Fandos, Noelia, Pérez-Grijalba, Virginia, Pesini, Pedro, Olmos, Salvador, Bossa, Matías, Villemagne, Victor L., Doecke, James, Fowler, Christopher, Masters, Colin L., Sarasa, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Blood-Based Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602863/
https://www.ncbi.nlm.nih.gov/pubmed/28948206
http://dx.doi.org/10.1016/j.dadm.2017.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602863/
https://www.ncbi.nlm.nih.gov/pubmed/28948206
http://dx.doi.org/10.1016/j.dadm.2017.07.004

Ejemplares similares